95 related articles for article (PubMed ID: 1911359)
1. Reduced platelet PDGF levels in idiopathic myelofibrosis.
Dolan G; Forrest PL; Eastham JM; Reilly JT
Br J Haematol; 1991 Aug; 78(4):586-8. PubMed ID: 1911359
[No Abstract] [Full Text] [Related]
2. Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Calvo F
Br J Haematol; 1991 Mar; 77(3):431-5. PubMed ID: 1901495
[TBL] [Abstract][Full Text] [Related]
3. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
4. Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis.
Eastham JM; Reilly JT; Mac Neil S
Br J Haematol; 1994 Mar; 86(3):668-70. PubMed ID: 8043453
[TBL] [Abstract][Full Text] [Related]
5. [Role of growth factors of platelets (PDGF, TGF-beta, EGF) in the pathogenesis of myelofibrosis].
Kimura A; Katoh O; Kuramoto A
Rinsho Byori; 1989 Apr; Spec No 81():1-8. PubMed ID: 2787864
[No Abstract] [Full Text] [Related]
6. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor AA homodimer is the predominant isoform in human platelets and acute human wound fluid.
Soma Y; Dvonch V; Grotendorst GR
FASEB J; 1992 Aug; 6(11):2996-3001. PubMed ID: 1644262
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
[TBL] [Abstract][Full Text] [Related]
10. [Megakaryoblastic transformation in polycythemia vera--a case of megakaryoblastic leukemia associated with myelofibrosis and elevation of serum PDGF-like activity].
Oda K; Katoh O; Kawano M; Iwato K; Kimura A; Imamura N; Fujimura K; Kuramoto A; Yasui W; Kajihara H
Rinsho Ketsueki; 1986 Nov; 27(11):2118-23. PubMed ID: 3820629
[No Abstract] [Full Text] [Related]
11. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus.
Nakashima N; Umeda F; Yamauchi T; Ishii H; Hisatomi A; Nawata H; Masuko H; Nakayama K; Tatematsu A
J Lab Clin Med; 1992 Jul; 120(1):78-85. PubMed ID: 1613332
[TBL] [Abstract][Full Text] [Related]
13. Platelet acquired defect in PDGF and beta thromboglobulin content in hairy cell leukaemia: improvement after interferon therapy.
Dupuy E; Sigaux F; Bryckaert MC; Tobelem G; Castaigne S; Flandrin G; Degos L; Caen JP
Br J Haematol; 1987 Jan; 65(1):107-10. PubMed ID: 2949773
[TBL] [Abstract][Full Text] [Related]
14. Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma).
Weibrich G; Kleis WK; Streckbein P; Moergel M; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2012; 27(4):762-9. PubMed ID: 22848876
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
16. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia.
Kimura A; Katoh O; Hyodo H; Kuramoto A; Satow Y
Leuk Lymphoma; 1995 Jul; 18(3-4):237-42. PubMed ID: 8535188
[TBL] [Abstract][Full Text] [Related]
17. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
18. Idiopathic myelofibrosis serum induces increased DNA synthesis in BALB/c 3T3 cells.
Polato G; Pietrogrande F; Caenazzo A; Piva E; Burlina A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):469-73. PubMed ID: 1703119
[TBL] [Abstract][Full Text] [Related]
19. Red cell production and destruction in primary myelofibrosis with reference to the neutrophil and platelet kinetics.
Uchida T; Umino M; Yui T; Kimura H; Tanaka T; Muroi S; Matsuda S; Kariyone S
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):31-6. PubMed ID: 7315143
[No Abstract] [Full Text] [Related]
20. Busy signal: platelet-derived growth factor activation in myelofibrosis.
Marneth AE; Mullally A
Haematologica; 2020 Aug; 105(8):1988-1990. PubMed ID: 32739885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
